243 related articles for article (PubMed ID: 25133395)
1. Cost of disorders of the brain in Spain.
Parés-Badell O; Barbaglia G; Jerinic P; Gustavsson A; Salvador-Carulla L; Alonso J
PLoS One; 2014; 9(8):e105471. PubMed ID: 25133395
[TBL] [Abstract][Full Text] [Related]
2. Cost of disorders of the brain in Europe 2010.
Gustavsson A; Svensson M; Jacobi F; Allgulander C; Alonso J; Beghi E; Dodel R; Ekman M; Faravelli C; Fratiglioni L; Gannon B; Jones DH; Jennum P; Jordanova A; Jönsson L; Karampampa K; Knapp M; Kobelt G; Kurth T; Lieb R; Linde M; Ljungcrantz C; Maercker A; Melin B; Moscarelli M; Musayev A; Norwood F; Preisig M; Pugliatti M; Rehm J; Salvador-Carulla L; Schlehofer B; Simon R; Steinhausen HC; Stovner LJ; Vallat JM; Van den Bergh P; van Os J; Vos P; Xu W; Wittchen HU; Jönsson B; Olesen J;
Eur Neuropsychopharmacol; 2011 Oct; 21(10):718-79. PubMed ID: 21924589
[TBL] [Abstract][Full Text] [Related]
3. Cost of disorders of the brain in Ireland.
McHugh JC; Murphy RP; Sobocki P
Ir Med J; 2007; 100(7):518-21. PubMed ID: 17886523
[TBL] [Abstract][Full Text] [Related]
4. [Cost of disorders of the brain in Austria in the year 2004].
Wancata J; Sobocki P; Katschnig H;
Wien Klin Wochenschr; 2007; 119(3-4):91-8. PubMed ID: 17347857
[TBL] [Abstract][Full Text] [Related]
5. Cost of depression in Europe.
Sobocki P; Jönsson B; Angst J; Rehnberg C
J Ment Health Policy Econ; 2006 Jun; 9(2):87-98. PubMed ID: 17007486
[TBL] [Abstract][Full Text] [Related]
6. Economic burden of bilateral neovascular age-related macular degeneration: multi-country observational study.
Cruess AF; Zlateva G; Xu X; Soubrane G; Pauleikhoff D; Lotery A; Mones J; Buggage R; Schaefer C; Knight T; Goss TF
Pharmacoeconomics; 2008; 26(1):57-73. PubMed ID: 18088159
[TBL] [Abstract][Full Text] [Related]
7. [Direct and indirect costs associated with respiratory allergic diseases in Italy. A probabilistic cost of illness study].
Marcellusi A; Viti R; Incorvaia C; Mennini FS
Recenti Prog Med; 2015 Oct; 106(10):517-27. PubMed ID: 26442978
[TBL] [Abstract][Full Text] [Related]
8. The economic cost of brain disorders in Europe.
Olesen J; Gustavsson A; Svensson M; Wittchen HU; Jönsson B; ;
Eur J Neurol; 2012 Jan; 19(1):155-62. PubMed ID: 22175760
[TBL] [Abstract][Full Text] [Related]
9. The size, burden and cost of disorders of the brain in the UK.
Fineberg NA; Haddad PM; Carpenter L; Gannon B; Sharpe R; Young AH; Joyce E; Rowe J; Wellsted D; Nutt DJ; Sahakian BJ
J Psychopharmacol; 2013 Sep; 27(9):761-70. PubMed ID: 23884863
[TBL] [Abstract][Full Text] [Related]
10. Cost of disorders of the brain in Luxembourg.
Bisdorff A; Sobocki P; Cloos JM; Andrée C; Graziano ME;
Bull Soc Sci Med Grand Duche Luxemb; 2006; (3):347-58. PubMed ID: 17209294
[TBL] [Abstract][Full Text] [Related]
11. Cost estimates of brain disorders in Belgium.
Schoenen J; Gianni F; Schretlen L; Sobocki P
Acta Neurol Belg; 2006 Dec; 106(4):208-14. PubMed ID: 17323838
[TBL] [Abstract][Full Text] [Related]
12. Prospective one-year cost-of-illness study in a cohort of patients with dementia of Alzheimer's disease type in Spain: the ECO study.
Coduras A; Rabasa I; Frank A; Bermejo-Pareja F; López-Pousa S; López-Arrieta JM; Del Llano J; León T; Rejas J
J Alzheimers Dis; 2010; 19(2):601-15. PubMed ID: 20110605
[TBL] [Abstract][Full Text] [Related]
13. The costs of disorders of the brain in Switzerland: an update from the European Brain Council Study for 2010.
Maercker A; Perkonigg A; Preisig M; Schaller K; Weller M;
Swiss Med Wkly; 2013; 143():w13751. PubMed ID: 23297120
[TBL] [Abstract][Full Text] [Related]
14. Social/economic costs and health-related quality of life in patients with scleroderma in Europe.
López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Kanavos P; Taruscio D; Schieppati A; Iskrov G; Péntek M; Delgado C; von der Schulenburg JM; Persson U; Chevreul K; Fattore G;
Eur J Health Econ; 2016 Apr; 17 Suppl 1():109-17. PubMed ID: 27038626
[TBL] [Abstract][Full Text] [Related]
15. Social/economic costs and health-related quality of life in patients with histiocytosis in Europe.
Iskrov G; Astigarraga I; Stefanov R; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Schieppati A; Taruscio D; Péntek M; von der Schulenburg JM; Kanavos P; Chevreul K; Persson U; Fattore G;
Eur J Health Econ; 2016 Apr; 17 Suppl 1():67-78. PubMed ID: 27042831
[TBL] [Abstract][Full Text] [Related]
16. Social/economic costs and health-related quality of life in patients with Prader-Willi syndrome in Europe.
López-Bastida J; Linertová R; Oliva-Moreno J; Posada-de-la-Paz M; Serrano-Aguilar P; Kanavos P; Taruscio D; Schieppati A; Iskrov G; Baji P; Delgado C; von der Schulenburg JM; Persson U; Chevreul K; Fattore G;
Eur J Health Econ; 2016 Apr; 17 Suppl 1():99-108. PubMed ID: 27038627
[TBL] [Abstract][Full Text] [Related]
17. Cost of disorders of the brain in Italy.
Pugliatti M; Sobocki P; Beghi E; Pini S; Cassano GB; Altamura AC; Pozzoli S; Rosati G;
Neurol Sci; 2008 Apr; 29(2):99-107. PubMed ID: 18483707
[TBL] [Abstract][Full Text] [Related]
18. The burden and cost of disorders of the brain in Europe with the inclusion of harmful alcohol use and nicotine addiction.
Effertz T; Mann K
Eur Neuropsychopharmacol; 2013 Jul; 23(7):742-8. PubMed ID: 22901735
[TBL] [Abstract][Full Text] [Related]
19. The economic burden of depression in Switzerland.
Tomonaga Y; Haettenschwiler J; Hatzinger M; Holsboer-Trachsler E; Rufer M; Hepp U; Szucs TD
Pharmacoeconomics; 2013 Mar; 31(3):237-50. PubMed ID: 23417609
[TBL] [Abstract][Full Text] [Related]
20. Cost-of-illness and disease burden of food-related pathogens in the Netherlands, 2011.
Mangen MJ; Bouwknegt M; Friesema IH; Haagsma JA; Kortbeek LM; Tariq L; Wilson M; van Pelt W; Havelaar AH
Int J Food Microbiol; 2015 Mar; 196():84-93. PubMed ID: 25528537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
